Author:
Hendriks H.R.,Pizao P.E.,Berger D.P.,Kooistra K.L.,Bibby M.C.,Boven E.,Dreef-van der Meulen H.C.,Henrar R.E.C.,Fiebig H.H.,Double J.A.,Hornstra H.W.,Pinedo H.M.,Workman P.,Schwartsmann G.
Reference40 articles.
1. Mitomycin analogs I. Indoloquinones as (potential) bisalkylating agents;Oostveen;Tetrahedron,1987
2. Preclinical antitumor profile of E09, a novel bioreductive alkylating indoloquinone derivative;Winograd,1989
3. DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs?;Workman;Br J Cancer,1989
4. The role of NAD(P)H: quinone reductase (EC1.6.99.2,DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumour agent E09;Walton;Cancer Commun,1991
5. Bioreductive activation of indoloquinone E09: involvement of DT-diaphorase and DNA crosslinking;Bailey;Ann Oncol,1992
Cited by
102 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献